Hazem Mustafa

Making precision medicine a reality

[Hazem Mustafa @BioadaFounder]

Parkinson’s doesn’t have a trial problem, it has a biology problem: https://t.co/gumrpCIvxQ

#Parkinsons #Neurodegeneration #DrugDiscovery #BiomedicalResearch #TranslationalMedicine #ScienceReform #FutureOfNeurology

[Hazem Mustafa @BioadaFounder]

Next-gen ADCs won’t save the modality without fundamental change, here’s why: https://t.co/qpaQYTADkw

#ADCs #Oncology #DrugDevelopment #Biopharma #PrecisionMedicine #BiomedicalInnovation #TranslationalScience #FutureOfTherapy

[Hazem Mustafa @BioadaFounder]

Recursion exposes the hard limits of AI-first drug discovery - biology still refuses to be abstracted away: https://t.co/4HzfI4PIiR

#AIinBiotech #DrugDiscovery #ComputationalBiology #TranslationalMedicine #LifeSciences #BiomedicalInnovation #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

After a decade and a billion dollars, the onset of the end for biomarker hype is finally here: https://t.co/2hNy0pj7nH

#Biomarkers #PrecisionMedicine #BiomedicalResearch #TranslationalScience #DrugDevelopment #HealthInnovation #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

Beyond the last mile - why what 10× Genomics got right isn’t enough, and what we solved years ago: https://t.co/q1CkcVSNw3

#Genomics #SingleCell #Bioinformatics #PrecisionMedicine #BiomedicalInnovation #TranslationalScience #FutureOfHealthcare

[Hazem Mustafa @BioadaFounder]

The GLP-1 megatrend’s final act: a payer reckoning that will redefine the market: https://t.co/EboZ7wIRep

#GLP1 #HealthcareEconomics #DrugPricing #PharmaMarket #PrecisionMedicine #Biotech #FutureOfHealth

[Hazem Mustafa @BioadaFounder]

“I told you so”, a stark reflection on where biomedical innovation went wrong: https://t.co/E2nXfxfp7N

#BiomedicalResearch #InnovationLessons #TranslationalMedicine #DrugDevelopment #ScienceReform #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

When will pharma finally learn that repeating old errors won’t create new breakthroughs: https://t.co/UJXnoO3Ncy

#Pharma #DrugDevelopment #BiomedicalInnovation #LifeSciences #ResearchReform #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

The GLP-1 megatrend’s next frontier? A powerful convergence with NLRP3 biology that's shaping the future of therapy: https://t.co/0WfckbYuLK

#GLP1 #NLRP3 #Inflammasome #MetabolicTherapy #PrecisionMedicine #BiomedicalInnovation #TranslationalScience

[Hazem Mustafa @BioadaFounder]

The GLP-1 megatrend’s next fault line? A biomarker void that could break the current model: https://t.co/Rgnm2ldo7T

#GLP1 #Biomarkers #PrecisionMedicine #MetabolicTherapy #DrugDevelopment #BiomedicalInnovation #FutureOfHealth

[Hazem Mustafa @BioadaFounder]

Expansion trials for ADCs keep faltering, here’s the silent killer behind the pipeline: https://t.co/2O7wGedoHY

#ADCs #DrugDevelopment #Oncology #Biopharma #ClinicalTrials #PharmaInnovation #TranslationalMedicine

[Hazem Mustafa @BioadaFounder]

The GLP‑1 receptor agonist megatrend’s blind spot is staring us in the face - why we still won’t admit it: https://t.co/IKascwyjGn

#GLP1 #MetabolicTherapy #TherapeuticBlindSpot #DrugMechanisms #BiomedicalInnovation #TranslationalMedicine

[Hazem Mustafa @BioadaFounder]

Simulating a cell isn’t the same as understanding it—the “virtual cell” risks becoming biology’s next illusion: https://t.co/YTqEJWmQiV

#VirtualCell #SystemsBiology #AIinBiotech #ComputationalBiology #TranslationalScience #BiomedicalInnovation #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

AI won’t revolutionize drug discovery until it learns to understand biology, not just generate it: https://t.co/WmgyQQMdae

#AIinBiotech #DrugDiscovery #ComputationalBiology #PrecisionMedicine #BiomedicalInnovation #TranslationalScience #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

Most drug programs don’t fail in trials, they fail before they begin, at the level of target misidentification: https://t.co/PhDPDH9NEP

#DrugDiscovery #TargetValidation #TranslationalMedicine #PharmaInnovation #PrecisionMedicine #BiomedicalResearch #FutureOfTherapeutics

[Hazem Mustafa @BioadaFounder]

Antibody-drug conjugates promise precision—but outdated thinking still binds their potential: https://t.co/YDmrne5wJX

#ADCs #Oncology #DrugDevelopment #Biopharma #PrecisionMedicine #BiomedicalInnovation #FutureOfCancerTherapy

[Hazem Mustafa @BioadaFounder]

Single-cell analysis is evolving—from clustering noise to true biological classification: https://t.co/bpXYAUqGhK

#SingleCell #MultiOmics #AIinBiology #PrecisionMedicine #Bioinformatics #BiomedicalInnovation #FutureOfScience

[Hazem Mustafa @BioadaFounder]

Drug development must pivot from mechanism-first silos to patient-first therapies—only then will translation truly succeed: https://t.co/smib5TTPDi

#DrugDiscovery #PrecisionMedicine #TranslationalResearch #BiomedicalInnovation #PatientCentric #FutureOfMedicine #PharmaReform

[Hazem Mustafa @BioadaFounder]

CAR T therapy shows dazzling innovation—but without solid foundations, it can’t last: https://t.co/HAXvdCo2yo

#CART #CellTherapy #Immunotherapy #Oncology #DrugDevelopment #BiomedicalInnovation #FutureOfMedicine

[Hazem Mustafa @BioadaFounder]

Biotech & pharma just paid $550M to relearn a lesson they still refuse to act on: https://t.co/diOYM0YKYd

#Biotech #Pharma #DrugDiscovery #BiomedicalInnovation #LifeSciences #PrecisionMedicine #FutureOfHealth